CAI logo

Caris Life Sciences, Inc. Stock Price

NasdaqGS:CAI Community·US$8.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 14 Fair Values set on narratives written by author

CAI Share Price Performance

US$29.94
1.94 (6.93%)
US$29.94
1.94 (6.93%)
Price US$29.94

CAI Community Narratives

There are no narratives available yet.

Snowflake Analysis

Exceptional growth potential and good value.

0 Risks
4 Rewards

Caris Life Sciences, Inc. Key Details

US$533.8m

Revenue

US$246.3m

Cost of Revenue

US$287.5m

Gross Profit

US$1.1b

Other Expenses

-US$798.6m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Nov 05, 2025
-2.84
53.86%
-149.59%
82.5%
View Full Analysis

About CAI

Founded
2008
Employees
1769
CEO
David Halbert
WebsiteView website
www.carislifesciences.com

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms. The company’s molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company was founded in 2008 and is headquartered in Irving, Texas.

Recent CAI News & Updates

Recent updates

No updates